On taking vows in two priesthoods, scientific and christian.

por Herrmann, R. L.
Publicado 1976

Flammenphotometrie

por Herrmann, R, Alkemade, C TH J
Publicado 1960

SELECTIVE PRESENTATION OF DNA-REGIONS AND MEMBRANES IN CHLOROPLASTS AND MITOCHONDRIA

por Herrmann, R. G., Kowallik, K. V.
Publicado 1970

Effects of fetal exposure to high-fat diet or maternal hyperglycemia on L-arginine and nitric oxide metabolism in lung

por Grasemann, C, Herrmann, R, Starschinova, J, Gertsen, M, Palmert, M R, Grasemann, H
Publicado 2017

Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy

por Bernhard, J, Dietrich, D, Glimelius, B, Hess, V, Bodoky, G, Scheithauer, W, Herrmann, R
Publicado 2010

Uncoupling of sexual reproduction from homologous recombination in homozygous Oenothera species

por Rauwolf, U, Greiner, S, Mráček, J, Rauwolf, M, Golczyk, H, Mohler, V, Herrmann, R G, Meurer, J
Publicado 2011

Molecular alterations in a patient with Turcot's syndrome.

por Rochlitz, C. F., Heide, I., de Kant, E., Neubauer, A., Schmidt, C. A., Neuhaus, P., Huhn, D., Herrmann, R.
Publicado 1993

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer

por Boulay, J-L, Mild, G, Lowy, A, Reuter, J, Lagrange, M, Terracciano, L, Laffer, U, Herrmann, R, Rochlitz, C
Publicado 2002

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer

por Boulay, J-L, Mild, G, Lowy, A, Reuter, J, Lagrange, M, Terracciano, L, Laffer, U, Herrmann, R, Rochlitz, C
Publicado 2003

Infrequent mutation of the tumour-suppressor gene Smad4 in early-stage colorectal cancer

por Mamot, C, Mild, G, Reuter, J, Laffer, U, Metzger, U, Terracciano, L, Boulay, J-L, Herrmann, R, Rochlitz, C
Publicado 2003

Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies

por Leyvraz, S, Herrmann, R, Guillou, L, Honegger, H P, Christinat, A, Fey, M F, Sessa, C, Wernli, M, Cerny, T, Dietrich, D, Pestalozzi, B
Publicado 2006

Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings

por Tartour, E, Mehtali, M, Sastre-Garau, X, Joyeux, I, Mathiot, C, Pleau, J M, Squiban, P, Rochlitz, C, Courtney, M, Jantscheff, P, Herrmann, R, Pouillart, P, Fridman, W H, Dorval, T
Publicado 2000